| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104205 Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof |
| 05/05/2011 | US20110104201 Porcine Reproductive and Respiratory Syndrome Vaccine Based on Isolate JA-142 |
| 05/05/2011 | US20110104200 Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines |
| 05/05/2011 | US20110104199 MVA Expressing Modified HIV Envelope, GAG, and POL Genes |
| 05/05/2011 | US20110104195 Plasmodium falciparum sporozoite and liver stage antigens |
| 05/05/2011 | US20110104194 Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization |
| 05/05/2011 | US20110104192 Norovirus and sapovirus antigens |
| 05/05/2011 | US20110104191 Malva mosaic virus and virus-like particles and uses thereof |
| 05/05/2011 | US20110104190 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 05/05/2011 | US20110104189 Compositions obtained from chlorella extract having immunomodulating properties |
| 05/05/2011 | US20110104188 Novel glycolipid and use thereof |
| 05/05/2011 | US20110104187 Method of treating glygogen storage disease |
| 05/05/2011 | US20110104186 Small molecule immunopotentiators and assays for their detection |
| 05/05/2011 | US20110104182 Cd40 antibody formulation and methods |
| 05/05/2011 | US20110104180 New vaccine for the treatment of mycobacterium related disorders |
| 05/05/2011 | US20110104178 Novel avian astrovirus |
| 05/05/2011 | US20110104173 Inhibition of degradation of extracellular matrix |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104168 Detoxified pneumococcal neuraminidase and uses thereof |
| 05/05/2011 | US20110104159 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 05/05/2011 | US20110104156 Methods and materials for treating autoimmune and/or complement mediated diseases and conditions |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104147 Identification of Tumor-Associated Markers for Diagnosis and Therapy |
| 05/05/2011 | US20110104145 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 05/05/2011 | US20110104144 Methods for treating cutaneous lupus using aminoisoindoline compounds |
| 05/05/2011 | US20110104134 Novel lactic acid bacterium having high immunoglobulin-a-inducing ability |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104115 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 05/05/2011 | US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds |
| 05/05/2011 | US20110104109 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 05/05/2011 | US20110104064 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals |
| 05/05/2011 | DE102009027754A1 Verfahren zur Hemmung der Reifung von dendritischen Zellen A method of inhibiting the maturation of dendritic cells |
| 05/05/2011 | CA2779615A1 Therapeutic nuclease compositions and methods |
| 05/05/2011 | CA2778895A1 Compositions and methods for treating inflammatory disorders |
| 05/05/2011 | CA2778893A1 Dna vaccine against the yellow fever virus |
| 05/05/2011 | CA2778680A1 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/05/2011 | CA2778372A1 Novel lactobacillus plantarum and composition comprising the same |
| 05/05/2011 | CA2777705A1 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom |
| 05/04/2011 | EP2316951A1 Binding domain-immunoglobulin fusion proteins |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316935A1 Aptamer against il-17 and use thereof |
| 05/04/2011 | EP2316924A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316923A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316858A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT) |
| 05/04/2011 | EP2316855A1 Antihuman Alpha-9 integrin antibody and use of the same |
| 05/04/2011 | EP2316852A1 Stabilized single domain antibodies |
| 05/04/2011 | EP2316834A1 Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase |
| 05/04/2011 | EP2316487A1 Recombinant IL-9 antibodies & uses thereof |
| 05/04/2011 | EP2316482A1 Transcutaneous immunostimulation |
| 05/04/2011 | EP2316478A1 Targeted therapeutic vaccine against P-glycoprotein 170 for inhibiting multi-drug resistance in the treatment of cancers |
| 05/04/2011 | EP2316476A2 Antigenic peptides derived from telomerase |
| 05/04/2011 | EP2316466A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/04/2011 | EP2316459A1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2316431A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol |
| 05/04/2011 | EP2315780A1 Compositions and methods of use for therapeutic antibodies |
| 05/04/2011 | EP2315778A2 Compositions monovalent for cd28 binding and methods of use |
| 05/04/2011 | EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 05/04/2011 | EP2315745A2 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 05/04/2011 | EP2315744A2 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 05/04/2011 | EP2315521A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h 4 receptor |
| 05/04/2011 | EP2128248B1 Oligonucleotide compositions with enhanced efficiency |
| 05/04/2011 | EP1867656B1 Compound having cyclic structure and use thereof |
| 05/04/2011 | EP1551412B1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1383532B1 Combination therapy |
| 05/04/2011 | EP1373261B1 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN102046780A Method for production of transfected cell |
| 05/04/2011 | CN102046777A Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production of the anti-allergic agent |
| 05/04/2011 | CN102046208A Composition for external application comprising transcription factor decoy as active ingredient |
| 05/04/2011 | CN102041175A Method for extracting total volatile oil and total alkaloids from zanthoxylum echinocarpum |
| 05/04/2011 | CN102040749A Ganoderma sinense mycelium polysaccharide refined substance as well as preparation method and use thereof |
| 05/04/2011 | CN102040748A Ganoderma sinensis mycelium anti-tumor polysaccharide component GS-C as well as preparation method and application thereof |
| 05/04/2011 | CN102040667A Method for biologically removing protein from sea cucumber polysaccharide |
| 05/04/2011 | CN102040662A Antibodies against human IL-21 receptor and uses therefor |
| 05/04/2011 | CN102040643A Ciclesonide nitrate derivative |
| 05/04/2011 | CN102040621A Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 05/04/2011 | CN102040552A 1, 2-di(cyclic group)substituted benzene derivative |
| 05/04/2011 | CN102038959A Application of let-7/miR-98 family in preparation of medicament for treating disease related to FAS (Fatty Acid Synthase) gene |
| 05/04/2011 | CN102038933A Combination of cyclosporine A and alkylation serum albumin and preparation method thereof |
| 05/04/2011 | CN102038842A Medicament for improving production performance of pigs and preparation method thereof |
| 05/04/2011 | CN102038820A Prepared Chinese medicine for improving and regulating autoimmune function of hepatitis B virus carriers |
| 05/04/2011 | CN102038705A Preparation method of green treatment and health-care liquid medicine |
| 05/04/2011 | CN102038703A New use of microRNA |
| 05/04/2011 | CN102038654A Cetirizine hydrochloride orally disintegrating tablets and preparation method thereof |
| 05/04/2011 | CN102038645A Desloratadine grain and preparation method thereof |
| 05/04/2011 | CN101612337B Traditional Chinese medicine health-care product for reinforcing immunity |
| 05/04/2011 | CN101575311B Method for preparing epiphysin |
| 05/04/2011 | CN101554442B Oral blood-clearing preparation |
| 05/04/2011 | CN101491533B Use of baicalin in preparing medicine |
| 05/04/2011 | CN101485841B Health-care granule containing astragalus and coix seed |
| 05/04/2011 | CN101422456B Preparation method and quality detection method for medicine composition drop-pills |
| 05/04/2011 | CN101406248B Nonspecific immunity strengthening agent for shrimps and crabs |
| 05/04/2011 | CN101347446B Medicament composition containing astragalus polysaccharide and ginseng bud saponin and uses thereof |
| 05/04/2011 | CN101323850B Lactobacillus helveticus microcapsule, preparation and use thereof |
| 05/04/2011 | CN101284871B Cyclic peptides with -Pro-Sta-Tyr- residue fragment as immunity inhibitor and synthesis process thereof |